Ignite Creation Date:
2025-12-24 @ 11:21 PM
Ignite Modification Date:
2026-02-01 @ 12:22 PM
Study NCT ID:
NCT03933956
Status:
TERMINATED
Last Update Posted:
2020-12-17
First Post:
2019-04-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Metabolic Effects of the SGLT-2 Inhibitor Empagliflozin in Patients With Diabetic Nephropathy (MEDiaN)
Sponsor:
Singapore General Hospital
Organization: